Related Experiment Video
Updated: May 30, 2025

13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.4K
Lymphomatoid Papulosis Type E With T-Cell Receptor Gamma Positivity.
Amornrut Namasondhi1, Suthinee Rutnin1, Suthep Jerasutus1
1Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Clinical, Cosmetic and Investigational Dermatology
|January 27, 2025
Summary
Lymphomatoid papulosis (LyP) is a skin disorder with subtypes. This case report details an unusual presentation of LyP type E with widespread eruptions, successfully treated with low-dose methotrexate.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Lymphomatoid papulosis (LyP) is a lymphoproliferative disorder with a chronic, relapsing course.
- Diagnosis relies on clinical and histopathological findings, with six recognized subtypes.
- LyP type E typically presents as large necrotic nodules/ulcers, characterized by angioinvasion/angiodestruction of CD8/CD30+ T cells.
Observation:
- This report describes an atypical case of LyP type E.
- The patient presented with widespread small papulonecrotic eruptions, deviating from the typical presentation.
- Immunohistochemistry revealed CD8, CD30, CD56, and TCR-γ positive atypical lymphocytes with angioinvasion.
Findings:
- The case highlights an unusual clinical manifestation of LyP type E.
- Atypical immunohistochemical profile with CD56 and TCR-γ positivity was observed.
- Successful treatment was achieved using low-dose methotrexate.
Implications:
- This case expands the understanding of LyP type E's clinical spectrum.
- It underscores the importance of considering atypical presentations in diagnosing LyP.
- Low-dose methotrexate may be an effective treatment option for such cases.

